Targeting Oncogenic Drivers and the Immune System in MelanomaMCARTHUR, Grant A; RIBAS, Antoni.Journal of clinical oncology. 2013, Vol 31, Num 4, pp 499-506, issn 0732-183X, 8 p.Article

The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in MelanomaSHEPPARD, Karen E; MCARTHUR, Grant A.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5320-5328, issn 1078-0432, 9 p.Article

Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinomaLIM, Annette M; YOUNG, Richard J; COLLINS, Marnie et al.Oral oncology (1997). 2012, Vol 48, Num 8, pp 698-702, issn 1368-8375, 5 p.Article

Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck CancerLE, Quynh-Thu; FISHER, Richard; O'SULLIVAN, Brian et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1798-1807, issn 1078-0432, 10 p.Article

RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF InhibitorsOBERHOLZER, Patrick A; KEE, Damien; PIRIS, Adriano et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 316-321, issn 0732-183X, 6 p.Article

Prognostic Significance of p16^INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialRISCHIN, Danny; YOUNG, Richard J; MCARTHUR, Grant A et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4142-4148, issn 0732-183X, 7 p.Article

Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic MelanomaTRUNZER, Kerstin; PAVLICK, Anna C; HERSEY, Peter et al.Journal of clinical oncology. 2013, Vol 31, Num 14, pp 1767-1774, issn 0732-183X, 8 p.Article

Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitorsSHEPPARD, Karen E; CULLINANE, Carleen; ELLUL, Jason et al.European journal of cancer (1990). 2013, Vol 49, Num 18, pp 3936-3944, issn 0959-8049, 9 p.Article

Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib FailureDEMETRI, George D; GARRETT, Christopher R; PAZ-ARES, Luis et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3170-3179, issn 1078-0432, 10 p.Article

Distinct clinical and pathological features are associated with the BRAF^{T1799A(V600E)} mutation in primary melanomaLIU, Wendy; KELLY, John W; MCARTHUR, Grant A et al.Journal of investigative dermatology. 2007, Vol 127, Num 4, pp 900-905, issn 0022-202X, 6 p.Article

Brcal inactivation induces p27^Kιp1-dependent cell cycle arrest and delayed development in the mouse mammary glandDEANS, Andrew J; SIMPSON, Kaylene J; TRIVETT, Melanie K et al.Oncogene (Basingstoke). 2004, Vol 23, Num 36, pp 6136-6145, issn 0950-9232, 10 p.Article

Combined Vemurafenib and Cobimetinib in BRAF-Mutated MelanomaLARKIN, James; ASCIERTO, Paolo A; DE LA CRUZ-MERINO, Luis et al.The New England journal of medicine. 2014, Vol 371, Num 20, pp 1867-1876, issn 0028-4793, 10 p.Article

Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III TrialLIM, Annette M; RISCHIN, Danny; LE, Quynh-Thu et al.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 301-307, issn 1078-0432, 7 p.Article

Relationship between Epidermal Growth Factor Receptor Status, p16^INK4A, and Outcome in Head and Neck Squamous Cell CarcinomaYOUNG, Richard J; RISCHIN, Danny; FISHER, Richard et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 6, pp 1230-1237, issn 1055-9965, 8 p.Article

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaBOLLAG, Gideon; HIRTH, Peter; BURTON, Elizabeth A et al.Nature (London). 2010, Vol 467, Num 7315, pp 596-599, issn 0028-0836, 4 p.Article

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanomaRANSON, Malcolm; HERSEY, Peter; BAKA, Sofia et al.Journal of clinical oncology. 2007, Vol 25, Num 18, pp 2540-2545, issn 0732-183X, 6 p.Article

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)HEINRICH, Michael C; MCARTHUR, Grant A; DIRNHOFER, Stephan et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1195-1203, issn 0732-183X, 9 p.Article

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib target exploration consortium study B2225MCARTHUR, Grant A; DEMETRI, George D; VAN OOSTEROM, Allan et al.Journal of clinical oncology. 2005, Vol 23, Num 4, pp 866-873, issn 0732-183X, 8 p.Article

Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcomeYOUNG, Richard J; LIM, Annette M; RUSSELL, Prudence A et al.Oral oncology (1997). 2013, Vol 49, Num 6, pp 576-581, issn 1368-8375, 6 p.Article

Regulatory T-Cell - Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant MelanomaNICHOLAOU, Theo; EBERT, Lisa M; LINDA PAN et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2166-2173, issn 1078-0432, 8 p.Article

IL-21 induces in vivo immune activation of NK cells and CD8⁺T cells in patients with metastatic melanoma and renal cell carcinomaFREDERIKSEN, Klaus Stensgaard; LUNDSGAARD, Dorthe; SKAK, Kresten et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 10, pp 1439-1449, issn 0340-7004, 11 p.Article

Translational control of c-MYC by rapamycin promotes terminal myeloid differentiationWALL, Meaghan; POORTINGA, Gretchen; HANNAN, Katherine M et al.Blood. 2008, Vol 112, Num 6, pp 2305-2317, issn 0006-4971, 13 p.Article

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersDAVID, Marianna; CROSS, Nicholas C. P; HUGUET, Francoise et al.Blood. 2007, Vol 109, Num 1, pp 61-64, issn 0006-4971, 4 p.Article

Cyclin-dependent kinase 2 functions in normal dna repair and is a therapeutic target in BRCA1-deficient cancersDEANS, Andrew J; KUM KUM KHANNA; MCNEES, Carolyn J et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8219-8226, issn 0008-5472, 8 p.Article

Rate of growth in melanomas : Characteristics and associations of rapidly growing melanomas. CommentaryLIU, Wendy; DOWLING, John P; MURRAY, William K et al.Archives of dermatology (1960). 2006, Vol 142, Num 12, issn 0003-987X, 1551-1558,1638-1640 [11 p.]Article